New hope for hard-to-treat depression? drug NV-5138 tested in 250 adults
NCT ID NCT05066672
First seen Apr 18, 2026 · Last updated May 15, 2026 · Updated 6 times
Summary
This study tested whether NV-5138 can safely reduce depression symptoms in adults whose depression did not get better with standard treatments. About 250 participants took either the drug or a placebo for 4 weeks. The main goal was to see if their depression scores improved more with NV-5138 than with placebo.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TREATMENT RESISTANT DEPRESSION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Northwest Clinical Research Center, Inc.
Bellevue, Washington, 98007, United States
Conditions
Explore the condition pages connected to this study.